We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YSS:NYSEYork Space Systems Inc. Analysis

Data as of 2026-06-07 - not real-time

$29.14

Latest Price

8/10Risk

Risk Level: High

Executive Summary

York Space Systems trades at $29.14, sitting below its 20‑day (30.13) and 50‑day (31.19) SMAs while remaining just above the 200‑day SMA (28.27), indicating a short‑term pull‑back within a neutral longer trend. The RSI of 46.9 and a bearish MACD histogram reinforce the technical downside pressure, and volume is on a decreasing trajectory. Volatility is extreme at 131% over the past 30 days and the stock’s beta of 2.31 signals heightened sensitivity to market swings. Fundamentally, the company posts a 9.5% revenue growth year‑over‑year, yet operating margins are deeply negative (‑89.9%) and profit margins sit at ‑47.3%, with EBITDA and operating cash flow both in the red. The balance sheet shows a strong cash position ($656 M) offset by a very high debt‑to‑equity ratio of 10.36, and the forward P/E of 54.6 far exceeds the industry average of 30.2, suggesting the stock is overvalued. Recent headlines flag a securities‑fraud investigation, adding a material regulatory headwind, while earnings guidance was reaffirmed despite an earnings miss. Overall, the blend of aggressive valuation, weak profitability, elevated risk metrics, and pending legal scrutiny creates a cautious outlook, even as the space sector’s long‑term upside remains compelling.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and decreasing volume
  • Securities fraud investigation
  • Price below short‑term moving averages

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Revenue growth and government contract pipeline
  • Strong cash cushion despite high debt
  • Industry tailwinds in the space sector

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Overvalued price multiples relative to fundamentals
  • High beta and volatility
  • Potential upside from long‑term aerospace demand

Key Metrics & Analysis

Financial Health

Revenue Growth9.50%
Profit Margin-47.35%
P/E Ratio54.6
Debt/Equity10.36
P/B Ratio1.7
Op. Cash Flow$-126289000
Industry P/E30.2

Technical Analysis

TrendNeutral
RSI46.9
Support$23.39
Resistance$37.86
MA 20$30.13
MA 50$31.19
MA 200$28.27
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Target Price$34.67
Upside/Downside18.97%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.31
Volatility131.53%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.